Top news of the week: 03.03.2023.
Kevzara® (sarilumab) approved by FDA as first and only biologic indicated for patients with polymyalgia rheumatica
CHANGES IN CERTAIN LABORATORY TEST RESULTS: Your healthcare provider should do blood tests before and after starting KEVZARA to check for low neutrophil (white blood cells that …
A radioactive prostate cancer therapy is a last lifeline for patients. Novartis can't make enough of it
Alfredo Najá Domingos’ prostate cancer was spreading. The malignant cells permeated his bones, kidney, lungs and liver, and in December, his oncologist told him there was no point in ...
Cell therapy biotech from Stanford CAR-T leader Crystal Mackall nabs $200M for PhII
A biotech born out of the work of Stanford CAR-T leader Crystal Mackall is publicly unveiling its $200 million Series A Wednesday, after already going through a Phase I clinical trial, ...
Struggling Novavax details a wave of red ink and plots survival course after raising 'going concern' alert
Novavax’s slow windup for its Covid-19 vaccine pitch has created a perilous stretch ahead for the longtime vaccine player. After the market closed on Tuesday, the company unveiled a ...
Suffering CNS player flips another losing hand in a last PhII gamble and calls for the axe
Ground down by repeated clinical failures and the collapse of its share price, one of Aptinyx’s last Phase II hands hit the table Monday after the stock closed. And it was another loser. ...
Top Pharmaceutical and Life Science Events in March (2023)
Top Pharmaceutical and Life Science events taking place in March 2023, including Biotechnology, Clinical Research, Drug Discovery and Medical Device events ...
ADC Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference
LAUSANNE, Switzerland--(BUSINESS WIRE)--ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will present a company overview at the Cowen 43rd Annual ...
JATT Acquisition Corp’s Proposed Business Combination With Zura Bio Limited Declared Effective by US SEC
Record date of Feb 26th 2023 established as well as;Extraordinary general meeting of shareholders to approve the Business Combination set for March 16th 2023LONDON--(BUSINESS WIRE)--JATT ...